Dissemin is shutting down on January 1st, 2025

Published in

Elsevier, Papillomavirus Research, (2), p. 17-20, 2016

DOI: 10.1016/j.pvr.2016.01.001

Links

Tools

Export citation

Search in Google Scholar

High specific immune response to a bivalent anti-HPV vaccine in HIV-1-infected men in São Paulo, Brazil

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Red circle
Postprint: archiving forbidden
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Infection with Human papillomavirus (HPV) has been reported as one of the most prevalent agent sexually transmitted diseases, but its true prevalence in men is not precisely known, mainly due to the near absence of symptoms. Moreover, few studies evaluating the post-vaccination immune response have been performed to date in men, hence the hypotheses tested in this study can be important to enable a better understanding of both the immunopathogenesis and the response to vaccination in HIV-infected patients, and to help in the elaboration of strategies of vaccination against HPV in the HIV-infected population.